Search results for "bisphosphonates."

showing 10 items of 66 documents

Mevalonate pathway: role of bisphosphonates and statins.

2011

Mevalonate; statins; bisphosphonatesSettore MED/09 - Medicina InternaMevalonatestatinbisphosphonates
researchProduct

Mode of action of herbicidal derivatives of aminomethylenebisphosphonic acid. I. Physiologic activity and inhibition of anthocyanin biosynthesis

1996

N-Pyridylaminomethylenebisphosphonic acids constitute a class of promising herbicides. Since their mode of action at the cellular level is still poorly understood, we studied the influence of N-pyridylaminomethylenebisphosphonic acids on plant growth, at the whole plant and undifferentiated tissue levels, using seedlings and cell suspension cultures of mono- and dicotyledonous species. These compounds exhibited strong herbicidal properties, being equipotent with the popular herbicide glyphosate. Since they also depressed buckweed anthocyanin biosynthesis, the shikimate pathway could represent a site of action of N-pyridylaminomethylenebisphosphonic acids.

N-Pyridylaminomethylenebisphosphonates; Anthocyanins; Herbicides; GlyphosateN-PyridylaminomethylenebisphosphonatesPlant physiologyPlant ScienceBiologyanthocyaninschemistry.chemical_compoundMetabolic pathwayherbicidesglyphosatechemistryMechanism of actionBiochemistryBiosynthesisAnthocyaninGlyphosatemedicineShikimate pathwaymedicine.symptomMode of actionAgronomy and Crop ScienceJournal of Plant Growth Regulation
researchProduct

Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series

2010

Abstract Purpose To report a case series of patients with the nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw—a form of jaw osteonecrosis that does not manifest with necrotic bone exposure/mucosal fenestration. Methods Among 332 individuals referred to 5 clinical centers in Europe because of development of jawbone abnormalities after or during exposure to bisphosphonates, we identified a total of 96 patients who presented with the nonexposed variant of osteonecrosis. Relevant data were obtained via clinical notes; radiological investigations; patients' history, and referral letters. Results The most common clinical feature of nonexposed osteonecrosis was jaw bone pa…

OsteochemonecrosisMaleTime FactorsAvascular necrosisMandibleAvascular necrosiEpidemiologyMaxillaProspective cohort studyMultiple myelomaAged 80 and overeducation.field_of_studyAlendronateBone Density Conservation AgentsDiphosphonatesOsteochemonecrosiOsteonecrosisGeneral MedicineBisphosphonatesMiddle AgedKidney NeoplasmsEuropeAvascular necrosisFemaleMultiple MyelomaAdultmedicine.medical_specialtyPopulationJawsBreast NeoplasmsSettore MED/28 - Malattie OdontostomatologicheJawbonesmedicineHumansBisphosphonateeducationAgedBisphosphonate-associated osteonecrosis of the jawbusiness.industryProstatic NeoplasmsAvascular necrosis; Bisphosphonates; Jawbones; Jaws; Mandible; Maxilla; Osteochemonecrosis; Osteonecrosismedicine.diseaseDermatologySurgeryJawMaxillaOsteoporosisJawbonebusinessOsteonecrosis of the jawJaw Diseases
researchProduct

Mandibular torus as known OnJ risk factor: a case report of osteonecrosis of the jaw

2015

Osteonecrosis jaw aminobisphosphonates torus
researchProduct

Criteria for the prescription of oral bisphosphonates for the treatment of osteoporosis in a series of women referred for tooth extraction

2012

Objective: To evaluate the criteria for the prescription of oral bisphosphonates (OB) in a series of women with osteoporosis referred for tooth extraction. Study design: The study included 38 postmenopausal women on treatment with OBs. The following variables were analysed: age, weight, height, type of OB and duration of treatment, bone densitometry and risk factors for osteoporosis. In addition, the osteoporosis self-assessment tool (OST) was administered and collagen type I C-telopeptide (CTX) levels were measured. Results: Bone densitometry had only been performed in six patients (15.7%) before starting OB treatment. Based on the results of the OST, nine (23.6%) of the participants prese…

OsteoporosisDentistryAdministration OralPostmenopausal osteoporosismedicineHumansMedical prescriptionGeneral DentistryAgedCollagen typeAged 80 and overPostmenopausal womenOral bisphosphonatesDiphosphonatesbusiness.industryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]OtorhinolaryngologyTooth ExtractionUNESCO::CIENCIAS MÉDICASOsteoporosisSurgeryResearch-ArticleFemaleOral SurgeryDensitometrybusiness
researchProduct

Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid

2015

Journal Article; Bisphosphonates (BP) are a type of drug known to inhibit bone resorption through complex interventions. Their primary mechanism of action is aimed at the cellular level, inhibiting osteoclast activity and so bone resorption. BPs are widely used, with many patients receiving continuous treatment for years. But it is well known that these drugs can produce osteonecrosis of the jaw (ONJ). Zoledronic acid (ZA) is an intravenous BP used in the treatment and prophylaxis of bone disease in patients with malignant tumors with bone implication. ZA is the most potent BP in clinical development. This report describes the case of a 62-year-old woman with breast cancer antecedents which…

Peri-implantitisBone diseasemedicine.medical_treatmentDifosfonatosDentistryCase Report:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Peri-implantitisDental implant:Chemicals and Drugs::Organic Chemicals::Organophosphorus Compounds::Diphosphonates [Medical Subject Headings]Implantes dentales:Anatomy::Cells::Connective Tissue Cells::Macrophages::Osteoclasts [Medical Subject Headings]ImidazolesOsteonecrosisBisphosphonates:Diseases::Neoplasms [Medical Subject Headings]:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludNeoplasiasHumanosmedicine.anatomical_structureNeoplasias de la mama:Chemicals and Drugs::Biomedical and Dental Materials::Dental Materials::Dental Implants [Medical Subject Headings]UNESCO::CIENCIAS MÉDICASMaxillectomy:Diseases::Stomatognathic Diseases::Mouth Diseases::Peri-Implantitis [Medical Subject Headings]Oral SurgeryResorción óseamedicine.drugmedicine.medical_specialtyOdontología:Diseases::Musculoskeletal Diseases::Bone Diseases::Osteonecrosis [Medical Subject Headings]Bone resorptionBreast cancerOsteoclast:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Azoles::Imidazoles [Medical Subject Headings]medicinePeriimplantitisGeneral DentistryZoledronic acid:Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings]Osteonecrosis of the jawbusiness.industry:Phenomena and Processes::Musculoskeletal and Neural Physiological Phenomena::Musculoskeletal Physiological Phenomena::Musculoskeletal Physiological Processes::Bone Remodeling::Bone Resorption [Medical Subject Headings]Osteoclastosmedicine.diseaseSurgeryZoledronic acid:Check Tags::Female [Medical Subject Headings]Osteonecrosis of the jawbusinessJournal of Clinical and Experimental Dentistry
researchProduct

Peri-implantitis-like medication-related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning m…

2021

Objective: In the recent years, an increasing number of peri-implant medication-related osteonecrosis of the jaw (PI-MRONJ) have been reported in literature, both in oncologic and osteoporotic patients. The aim of this study is to describe 19 cases of patients previously diagnosed as affected by peri-implantitis, who were treated for PI-MRONJ, with consideration on clinical and histopathological features. Materials and Methods: Patients included were affected by postmenopausal osteoporosis and were administered with different antiresorptive drugs. Due to the presence of clinical and radiological signs of peri-implantitis not healed after non-surgical periodontal treatment, they were referre…

Peri-implantitisConfocal laser scanning microscopeDentistryantiangiogenic drugs; antiresorptive drugs; bisphosphonates; medication-related osteonecrosis of the jaw; peri-implantitis03 medical and health sciences0302 clinical medicineMedicineHumansantiresorptive drugsmedication-related osteonecrosis of the jawantiangiogenic drugsDental CareGeneral DentistryPathologicalbisphosphonatesWound HealingBone Density Conservation AgentsDiphosphonatesLS7_8business.industryAmbientale030206 dentistryDrug holidaymedicine.diseaseAntiresorptive DrugsOtorhinolaryngology030220 oncology & carcinogenesisRadiological weaponBisphosphonate-Associated Osteonecrosis of the JawImplantbusinessOsteonecrosis of the jawperi-implantitis
researchProduct

Where could gammadelta T cells take us in the treatment of cancer?

2022

N/A

Pharmacologycancer immunotherapyCAR-T cellsallogeneic cellsClinical BiochemistryDrug Discoveryphosphoantigensbisphosphonatesγδ T cellsAdoptive cell therapyExpert Opinion on Biological Therapy
researchProduct

Advances in immunotherapy of castration-resistant prostate cancer: Bisphosphonates, phosphoantigens and more.

2008

Settore MED/04 - Patologia Generaleprostate cancer bisphosphonates gamma delta T cells
researchProduct

Mucosal healing following PRP (Platelet-Rich Plasma) application in post-extraction socket in patients treated with aminobisphosphonates

2014

Settore MED/28 - Malattie Odontostomatologichemucosal healing PRP Platelet-Rich Plasma aminobisphosphonates surgery extraction
researchProduct